Septerna (SEPN) Cash from Operations (2023 - 2026)
Septerna (SEPN) recorded quarterly Cash from Operations of 25633000.0 in Q1 2026, down 71.02% quarter-over-quarter from 14988000.0 in Q4 2025, and down 9.81% on a YoY basis from 28421180.78 in Q1 2025.
Septerna (SEPN) Cash from Operations (2023 - 2026) Analysis & Trends
Septerna's Cash from Operations history runs 4 years deep, the most recent figure standing at 25633000.0 for Q1 2026.
- In Q1 2026, Cash from Operations fell 9.81% year-over-year to 25633000.0; the TTM figure through Mar 2026 stood at 107899000.0 (up 245.61% YoY), while the FY2025 annual figure was 110189000.0, up 263.32% from the prior year.
- Cash from Operations was 25633000.0 for Q1 2026 at Septerna, down from 14988000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 168807000.0 in Q3 2025 to a low of 25633000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 828900.0 across 4 years, with a median of 16762500.0 in 2024.
- The sharpest annual moves came in 2024 and 2025: Cash from Operations sank 138.24% in 2024, then soared 1103.97% in 2025.
- A 4-year view of Cash from Operations shows it stood at 8797000.0 in 2023, then sank by 138.24% to 20958000.0 in 2024, then increased by 28.49% to 14988000.0 in 2025, then tumbled by 71.02% to 25633000.0 in 2026.
- The last three Cash from Operations figures came in at 25633000.0 (Q1 2026), 14988000.0 (Q4 2025), and 168807000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Septerna | 1.62 Bn | 1.62 Bn | - | -25.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -25.63 Mn |
| Mar 31, 2026 | -25.63 Mn |
| Dec 31, 2025 | -14.99 Mn |
| Dec 31, 2025 | -14.99 Mn |
| Sep 30, 2025 | 168.81 Mn |
| Sep 30, 2025 | 168.81 Mn |
| Jun 30, 2025 | -20.29 Mn |
| Jun 30, 2025 | -20.29 Mn |
| Mar 31, 2025 | -23.34 Mn |
| Mar 31, 2025 | -23.34 Mn |
| Dec 31, 2024 | -20.96 Mn |
| Dec 31, 2024 | -20.96 Mn |
| Sep 30, 2024 | -16.81 Mn |
| Sep 30, 2024 | -16.81 Mn |
| Jun 30, 2024 | -12.99 Mn |
| Jun 30, 2024 | -12.99 Mn |
| Mar 31, 2024 | -16.71 Mn |
| Mar 31, 2024 | -16.71 Mn |
| Dec 31, 2023 | -8.80 Mn |
| Dec 31, 2023 | -8.80 Mn |